We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
FedEx
FDX
$72.7B
| $906K | 0.01% |
+6,829
| New | +$928K |
|
477
Coca-Cola
KO
$377B
| $906K | 0.01% |
+23,429
| New | +$905K |
|
|
DNB
478
CALL
DELISTED
Dun & Bradstreet
DNB
| $905K | 0.01% |
+9,100
| New | +$958K |
|
479
Aon
AON
$76.5B
| $902K | 0.01% |
10,699
+7,044
| +193% | +$586K |
|
480
Duke Energy
DUK
$97.8B
| $900K | 0.01% |
12,634
-23,138
| -65% | -$1.61M |
|
481
Nabors Industries
NBR
$1.27B
| $900K | 0.01% |
730
+376
| +106% | +$375K |
|
482
Harley-Davidson
HOG
$2.58B
| $897K | 0.01% |
13,454
+7,474
| +125% | +$494K |
|
483
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $894K | 0.01% |
45,566
+4,557
| +11% | +$87K |
|
484
PUT
Avis
CAR
$4.86B
| $888K | 0.01% |
+18,200
| New | +$782K |
|
485
Nike
NKE
$61.9B
| $887K | 0.01% |
+24,014
| New | +$908K |
|
|
BRE
486
DELISTED
BRE PROPERTIES INC CL A
BRE
| $884K | 0.01% |
14,066
-175,450
| -93% | -$10.6M |
|
|
EXXI
487
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $873K | 0.01% |
+37,016
| New | +$870K |
|
488
Moody's
MCO
$82.8B
| $870K | 0.01% |
+10,964
| New | +$859K |
|
489
CDW
CDW
$18.9B
| $868K | 0.01% |
+31,591
| New | +$781K |
|
|
CMA
490
DELISTED
Comerica
CMA
| $859K | 0.01% |
+16,577
| New | +$797K |
|
491
Ecolab
ECL
$78.1B
| $859K | 0.01% |
7,948
-5,911
| -43% | -$619K |
|
|
492
Gilead Sciences
GILD
$162B
| $859K | 0.01% |
12,116
-1,097,797
| -99% | -$86.1M |
|
493
Bunge Global
BG
$20.4B
| $854K | 0.01% |
10,729
-2,759
| -20% | -$217K |
|
|
EVHC
494
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $850K | 0.01% |
+8,383
| New | +$839K |
|
|
ETRM
495
DELISTED
EnteroMedics Inc.
ETRM
| $842K | 0.01% |
+440
| New | +$1.04M |
|
|
EGN
496
DELISTED
Energen
EGN
| $836K | 0.01% |
+10,344
| New | +$775K |
|
|
DO
497
DELISTED
Diamond Offshore Drilling
DO
| $818K | 0.01% |
16,768
+12,777
| +320% | +$630K |
|
|
SNDK
498
DELISTED
SANDISK CORP
SNDK
| $812K | 0.01% |
9,995
-27,606
| -73% | -$2.04M |
|
|
STI
499
DELISTED
SunTrust Banks, Inc.
STI
| $807K | 0.01% |
20,268
+8,268
| +69% | +$316K |
|
500
Palo Alto Networks
PANW
$270B
| $804K | 0.01% |
+70,302
| New | +$798K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.